- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 20, 2025 | 482.56M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 392.37M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 349.49M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$426.29K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$168.23K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$9.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$15.71M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.05M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.47M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $8.81M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $15.9M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.02 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $21.59K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $308.61K |
| Net Income | Q1 2025 · Mar 31, 2025 | $6.54M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.02M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$4.21M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.61M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $405.14K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.05M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $8.17K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.05M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $500.33K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $539.56K |
| Capex | Q1 2025 · Mar 31, 2024 | $53.9K |